Serotonin News and Research

Latest Serotonin News and Research

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Aspirin can reduce acute migraine attacks

Aspirin can reduce acute migraine attacks

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Stress and genetic factors may raise depression among medical interns

Stress and genetic factors may raise depression among medical interns

Worsening suicidality thoughts while on antidepressants linked to specific changes in brain function

Worsening suicidality thoughts while on antidepressants linked to specific changes in brain function

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

Study: Genetic mutation in mice elevates risk of stress-induced depression

Study: Genetic mutation in mice elevates risk of stress-induced depression

Rexahn Pharmaceuticals submits Phase II protocol for study of Serdaxin in treatment of PD

Rexahn Pharmaceuticals submits Phase II protocol for study of Serdaxin in treatment of PD

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

Addiction to high calorie fat rich food: likened to cocaine and heroin addiction

Addiction to high calorie fat rich food: likened to cocaine and heroin addiction

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Clinical Data completes NDA submission for vilazodone

Clinical Data completes NDA submission for vilazodone

IDT: Military application of Transcendental Meditation for preventing war and terrorism

IDT: Military application of Transcendental Meditation for preventing war and terrorism

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

StockPreacher.com: ACAD reports net loss of $8.7M for fourth-quarter of 2009

Antidepressants effective against depression in patients suffering from physical illnesses

Antidepressants effective against depression in patients suffering from physical illnesses

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.